Indication

Mild persistent asthma

Mild persistent asthma is a clinical severity classification of chronic asthma affecting the lower respiratory tract in pediatric and adult populations. Read more about Mild persistent asthma

45 drugs 37 manufacturers

Advertisement

Drugs that treat it

Common Mild persistent asthma therapies.

Showing 1–9 of 45 drugs

Filter & compare in the drug finder →Opens the drug finder with Mild persistent asthma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mild persistent asthma.

Mild persistent asthma is a clinical severity classification of chronic asthma affecting the lower respiratory tract in pediatric and adult populations.

It is pathophysiologically driven by chronic airway inflammation, bronchial hyperresponsiveness, and variable airflow limitation.

Clinically, it is defined by daytime respiratory symptoms—such as wheezing, dyspnea, chest tightness, or cough—occurring more than twice per week but less than daily, and nighttime awakenings occurring three to four times per month.

Patients typically experience minor interference with normal daily activities and demonstrate preserved baseline pulmonary function, generally maintaining a forced expiratory volume in one second (FEV1) of at least 80 percent of predicted.

Personalize your experience

Follow Mild persistent asthma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it